IDT Australia Limited (AU:IDT) has released an update.
IDT Australia Limited, a pharmaceutical manufacturing company, has announced a fully underwritten entitlement offer to raise $7 million. The capital will fund advancements in mRNA therapeutics and enhance IDT’s capabilities in Antibody Drug Conjugate production, catering to an expected rise in work orders. Additionally, the company has received a non-binding indicative offer from Myndbio Pty Ltd for a potential acquisition, though no definitive agreement has been established.
For further insights into AU:IDT stock, check out TipRanks’ Stock Analysis page.
